A Pure Antiestrogen, ICI 182,780, Stimulates the Growth of Tamoxifen-Resistant KPL-1 Human Breast Cancer Cells in vivo but not in vitro

Publisher： Karger

E-ISSN： 1423-0232|55|1|23-34

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.1, 1998-12, pp. : 23-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paradoxical Hormone Responses of KPL-1 Breast Cancer Cells in vivo: A Significant Role of Angiogenesis in Tumor Growth

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Research provides new hope for tamoxifen-resistant breast cancer patients

By  

Women's Health, Vol. 4, Iss. 2, 2008-03 ,pp. : 115-117

Future Medicine

Access to resources Recommend Favorite

Approaches Targeted to Estrogen Receptors for Treatment of Tamoxifen-Resistant Breast Cancer: A Brief Overview

By  

Oncology, Vol. 59, Iss. 1, 2000-11 ,pp. : 3-4

Karger

Access to resources Recommend Favorite

The effects of gefitinib in tamoxifen‐resistant and hormone‐insensitive breast cancer: A phase II study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 126, Iss. 8, 2010-04 ,pp. : 1806-1816

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of radioresistance in drug resistant human MCF-7 breast cancer cells

By  

Journal of Radiotherapy in Practice, Vol. 8, Iss. 4, 2009-12 ,pp. : 207-213

Cambridge University Press

Access to resources Recommend Favorite